|
Name |
6-Hydroxylpaspalinine
|
Molecular Formula | C27H31NO4 | |
IUPAC Name* |
(1R,2R,4S,5S,16S,19R,23R)-2-hydroxy-4,5,24,24-tetramethyl-25,26-dioxa-7-azaheptacyclo[21.2.1.01,20.04,19.05,16.06,14.08,13]hexacosa-6(14),8,10,12,20-pentaen-22-one
|
|
SMILES |
C[C@]12C[C@H]([C@]34C(=CC(=O)[C@H](O3)C(O4)(C)C)[C@@H]1CC[C@@H]5[C@@]2(C6=C(C5)C7=CC=CC=C7N6)C)O
|
|
InChI |
InChI=1S/C27H31NO4/c1-24(2)23-20(29)12-18-17-10-9-14-11-16-15-7-5-6-8-19(15)28-22(16)26(14,4)25(17,3)13-21(30)27(18,31-23)32-24/h5-8,12,14,17,21,23,28,30H,9-11,13H2,1-4H3/t14-,17-,21+,23-,25-,26+,27+/m0/s1
|
|
InChIKey |
SMUWWVMLCRYVKW-GOJHYGRYSA-N
|
|
Synonyms |
6-hydroxylpaspalinine
|
|
CAS | NA | |
PubChem CID | 139590473 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 433.5 | ALogp: | 3.6 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 71.6 | Aromatic Rings: | 7 |
Heavy Atoms: | 32 | QED Weighted: | 0.628 |
Caco-2 Permeability: | -5.233 | MDCK Permeability: | 0.00002280 |
Pgp-inhibitor: | 0.998 | Pgp-substrate: | 0.502 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.022 |
30% Bioavailability (F30%): | 0.556 |
Blood-Brain-Barrier Penetration (BBB): | 0.861 | Plasma Protein Binding (PPB): | 94.10% |
Volume Distribution (VD): | 2.069 | Fu: | 2.80% |
CYP1A2-inhibitor: | 0.07 | CYP1A2-substrate: | 0.967 |
CYP2C19-inhibitor: | 0.195 | CYP2C19-substrate: | 0.885 |
CYP2C9-inhibitor: | 0.299 | CYP2C9-substrate: | 0.042 |
CYP2D6-inhibitor: | 0.035 | CYP2D6-substrate: | 0.244 |
CYP3A4-inhibitor: | 0.836 | CYP3A4-substrate: | 0.862 |
Clearance (CL): | 5.639 | Half-life (T1/2): | 0.116 |
hERG Blockers: | 0.042 | Human Hepatotoxicity (H-HT): | 0.562 |
Drug-inuced Liver Injury (DILI): | 0.23 | AMES Toxicity: | 0.843 |
Rat Oral Acute Toxicity: | 0.989 | Maximum Recommended Daily Dose: | 0.96 |
Skin Sensitization: | 0.539 | Carcinogencity: | 0.953 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.012 |
Respiratory Toxicity: | 0.985 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005990 | 0.613 | D0H4JM | 0.289 | ||||
ENC005988 | 0.596 | D0U7GP | 0.289 | ||||
ENC003928 | 0.569 | D01JGV | 0.289 | ||||
ENC002279 | 0.566 | D06CWH | 0.277 | ||||
ENC000836 | 0.517 | D02QJH | 0.275 | ||||
ENC003172 | 0.513 | D02JNM | 0.274 | ||||
ENC005989 | 0.513 | D05MQK | 0.270 | ||||
ENC002951 | 0.509 | D06IIB | 0.270 | ||||
ENC005405 | 0.504 | D0P0HT | 0.266 | ||||
ENC005406 | 0.500 | D03ZZK | 0.260 |